Abstract:Several aromatic amines (AA) are classified as human carcinogens, and tobacco smoke is one of the main sources of exposure. Once in the human body, they undergo different metabolic pathways which lead to either their excretion or ultimately to the formation of DNA and protein adducts. The aim of this study was to investigate AA in 68 urine samples (aged 29–79, 47% female), including 10 smokers (S), 28 past-smokers (PS) and 30 never-smokers (NS), and to study if there was a relation between the smoking status and the amount of the AA present. GCxGC-MS was used to analyze AA in complex urine samples due to its high peak capacity and the fact that it provides two sets of retention times and structural information, which facilitates the separation and identification of the target analytes. First, a qualitative comparison of an example set of a NS, PS and S sample was carried out, in which 38, 45 and 46 AA, respectively, could be tentatively identified. Afterwards, seven AA were successfully quantified in the samples. Of these, 4-ethylaniline (4EA, p = 0.015), 2,4,6-trimethylaniline (2,4,6TMA, p = 0.030), 2-naphthylamine (2NA, p = 0.014) and the sum of 2,4- and 2,6-dimethylaniline (DMA, p = 0.017) were found in significantly different (α = 0.05) concentrations for the S, 29 ± 14, 87 ± 49, 41 ± 26, and 105 ± 57 ng/L respectively, compared to the NS, 15 ± 6, 42 ± 30, 16 ± 6, and 48 ± 28 ng/L. And 2,4,6TMA (39 ± 26, p = 0.022), 2NA (18 ± 9, p = 0.025) and DMA (53 ± 46, p = 0.030), were also found at significantly higher concentrations in samples from S when compared to PS. However, some samples had AA concentrations outside the calibration curve and could not be taken into account, especially for 2-methylaniline (2MA). Therefore, all the samples were evaluated using a quantitative screening approach, by which the intensities of 4EA (p = 0.019), 2,4,6TMA (p = 0.048), 2NA (p = 0.016), DMA (p = 0.019) and 2MA (p = 0.006) in S were found to be significantly (α = 0.05) higher than in the NS, and 2MA (p = 0.019) and 4EA (p = 0.023) in S were found to be significantly higher than in the PS. An association between the smoking status and the amount of certain AA present could therefore be found. This information could be used to study the relation between the smoking status, the amount of AA present, and smoking related diseases like bladder cancer.

Analysis of aromatic amines in human urine using comprehensive multi-dimensional gas chromatography-mass spectrometry (GCxGC-MS)

Determination of aromatic amines in human urine using comprehensive multi-dimensional gas chromatography mass spectrometry (GCxGC-qMS)

Determination of Urinary Heterocyclic Aromatic Amines in Smokers and Non-Smokers by Using Sensitive and High Throughput Liquid Chromatography-Tandem Mass Spectrometry

Determination of urinary aromatic amines in smokers and nonsmokers using a MIPs-SPE coupled with LC-MS/MS method.

Variability in urinary concentrations of primary aromatic amines

A liquid chromatography-tandem mass spectrometry method for the analysis of primary aromatic amines in human urine

Assessment of the Exposure to Aromatic Amines in Users of Various Tobacco/Nicotine Products

Simultaneous Determination of Fifteen Heterocyclic Aromatic Amines in the Urine of Smokers and Nonsmokers Using Ultra-High Performance Liquid Chromatography–tandem Mass Spectrometry

Short- and Long-Term Stability of Aromatic Amines in Human Urine

Tobacco Smoke Is a Major Source of Aromatic Amine Exposure in U.S. Adults: 2013-2014 National Health and Nutrition Examination Survey (NHANES)

Evaluation of Tobacco Smoke and Diet As Sources of Exposure to Two Heterocyclic Aromatic Amines for the US Population: NHANES 2013-2014

Assessment of urinary aromatic amines in Brazilian pregnant women and association with DNA damage: Influence of genetic diversity, lifestyle, and environmental and socioeconomic factors

Rapid and Simultaneous Analysis of Ten Aromatic Amines in Mainstream Cigarette Smoke by Liquid Chromatography/electrospray Ionization Tandem Mass Spectrometry under ISO and “health Canada Intensive” Machine Smoking Regimens

Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkers

Rapid determination of six carcinogenic primary aromatic amines in mainstream cigarette smoke by two-dimensional online solid phase extraction combined with liquid chromatography tandem mass spectrometry

High-throughput and sensitive analysis of urinary heterocyclic aromatic amines using isotope-dilution liquid chromatography–tandem mass spectrometry and robotic sample preparation system

Analysis of six aromatic amines in the mainstream smoke of tobacco products

Determination of cotinine, phenylglyoxylic acid and mandelic acid in human urine by GC/MS]

New Validated LC-MS/MS Method for the Determination of Three Alkylated Adenines in Human Urine and Its Application to the Monitoring of Alkylating Agents in Cigarette Smoke

Quantitative Analysis of Five Tobacco-Specific N-Nitrosamines in Urine by Liquid Chromatography-Atmospheric Pressure Ionization Tandem Mass Spectrometry

Urinary and fecal excretion of aromatic amines in pet dogs and cats from the United States